Search

everythinglearnresearchcommunity

for

Search:↓

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Basonuclin may help control ribosomal RNA gene activity in skin cells.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.

Ustekinumab helped three kids with alopecia areata regrow hair.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Nonmelanoma skin cancers have higher levels of certain osteopontin variants than normal skin.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Combining mesotherapy with systemic treatments effectively improves alopecia universalis treatment.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

FOL-005 peptide can reduce human hair growth by lowering FGF7 levels.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

High MUC-18/MCAM levels in blood indicate a worse outlook for melanoma patients.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.